Glyn Ed­wards takes chair­man role at UK on­colyt­ic virus start­up emerg­ing out of stealth

On­colyt­ic virus­es — virus­es that can se­lec­tive­ly repli­cate in can­cer cells and kill them — have been steadi­ly at­tract­ing in­vest­ment and cu­rios­i­ty. How­ev­er, for the most part …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER